A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Dr. Joseph Ricotta Completes 200th TCAR Procedure at Delray Medical

Joseph J. Ricotta, MD, MS, DFSVS, FACS,  National Medical Director for Vascular Surgery and Endovascular Therapy for Tenet Healthcare recently completed his 200th Transcarotid Artery Revascularization (TCAR) stroke prevention procedure at Delray Medical Center.

Dr. Joseph Ricotta was first in the State of Florida to perform the TCAR procedure in 2018. For patients diagnosed with carotid artery disease, the TCAR procedure is a minimally invasive approach compared with traditional surgical procedures such as carotid endarterectomy. The TCAR procedure is suited for patients who are at a higher risk of surgical complications due to age, medical co-morbidities, or anatomical issues.

In 2020, Dr. Ricotta received the national TCAR Clinical Operator of Experience distinction. Silk Road Medical, manufacturer of the TCAR device for patient procedures, awards select physicians throughout the country with this accolade who have demonstrated clinical excellence and superior quality outcomes using TCAR to treat patients with carotid artery disease.

“TCAR is a new treatment alternative for patients with carotid artery disease aimed to prevent a stroke. Carotid artery disease is the most common cause of stroke and usually occurs when plaque in the carotid artery breaks off and travels to the brain or impedes blood flow which can also cause a stroke,” said Dr. Ricotta.

During a TCAR procedure, Dr. Ricotta makes a small incision above the clavicle to access the carotid artery and insert a pliable sheath. The sheath links to a component temporarily reversing blood away from the brain in an effort to avert any plaque from traveling to the patient’s brain. With this reverse-flow neuroprotection in place, Dr. Ricotta performs balloon angioplasty and implants a stent inside of the carotid artery lesion to achieve long-term plaque stabilization and stroke prevention as well as open blood flow to the brain. Throughout the TCAR procedure, the blood filters removing any plaque or clot before returning to the body via an additional sheath in the femoral vein of the patient’s thigh. Once Dr. Ricotta places the stent in the artery to eliminate the plaque, the reversal flow mechanism switches and blood flows freely to the brain into its intended path free from stroke inducing plaque.

“If you compare TCAR to traditional carotid endarterectomy surgical treatment, TCAR carries a lower risk of stroke, heart attack, and death. TCAR is quicker than a traditional surgery with a shorter hospital stay (<24 hours) and less chance of bleeding, nerve injury, or re-intervention,” said Dr. Ricotta.

Dr. Ricotta performs the TCAR procedure in Delray Medical Center’s Endovascular Hybrid Operating Room Suite. At Dr. Ricotta’s Prime Vascular Institute medical practice in Delray Beach, a non-invasive Doppler ultrasound is available to diagnose a patient’s carotid artery disease.

Prime Vascular Institute is located at 4205 W. Atlantic Ave., Building B, Suite 201, Delray Beach, FL, 33445. For more information visit: PrimeVascular.com or call Dr. Ricotta’s office at 561-303-0013. In addition, Dr. Ricotta is on-staff at Delray Medical Center.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy